| Name | Title | Contact Details |
|---|
Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies only target one component of the immunosuppressive TME and a broader, more multi-faceted therapeutic approach is required. We are a team on a mission to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology research. Our diverse clinical and preclinical pipeline of immune-enhancing antibody candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies for patients and their families. Surface is leveraging its deep understanding of TME biology to target factors and cells that suppress patients’ anti-tumor immune response. Our broad attack on the TME has the potential to convert patients’ non-responsive ‘cold’ tumors into immune-active ones. We push ourselves to break through across all dimensions of our work. From a discovery perspective, Surface leverages its world-class SAB to identify new targets and takes an aggressive approach towards generating diverse, highly-specific antibodies, which allows our scientists to thoroughly explore the relevant biology. Our antibody discovery approach generates therapeutic-quality antibodies, as well as unique tools to explore the biology of the tumor microenvironment.
Remedy Partners delivers software and services that enable payers, employers and at-risk providers to organize and finance healthcare delivery around a patient`s episode of care. For healthcare providers, Remedy Partners` software, analytics and administrative services support bundled payment contracts with Medicare and Commercial Insurers, often through shared-risk partnerships. For payers, Remedy Partners empowers the development of bundled payment contracting programs and guides development of bundled payment networks. Remedy Partners presently delivers its services to partners at more than 1,000 healthcare locations nationwide.
Civitas Senior Living is a team of senior living experts that provide all facets of senior living operations. This expertise includes extensive experience in Assisted Living, Memory Care, and Independent Living. Through third-party management contracts, Civitas provides expert management services for operational start-ups, turn-around operations, and on-going operations. Civitas Senior Living works closely with developers to optimize operations through developing partnerships that align interests. When contracting with Civitas Senior Living, you are partnering with an experienced operator that is also an owner. This ownership experience provides a proven track record of operating properties with excellent financial returns and high occupancy rates while focusing on customer satisfaction.
Integrated healthcare business solutions is a Franklin, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orthopaedic Associates of Michigan is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.